Feng Zhang (張鋒), a 2016 Tang Prize winner, explained his latest genome editing tool, called CRISPR/Cas13, in a meeting Wednesday with Tang Prize Foundation CEO Chern Jenn-chuan (陳振川) and a Nobel Prize laureate in Physiology or Medicine at the Massachusetts Institute of Technology (MIT).
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
-
Society
Taiwan CDC raises Ebola travel advisory for DRC, Uganda
05/20/2026 04:44 PM -
Politics
Lai, KMT trade barbs over cross-strait policy differences
05/20/2026 03:49 PM -
Business
Carrefour, no more: Supermarket chain to use new name from July
05/20/2026 03:37 PM -
Politics
Cabinet approves NT$295 billion special budget for U.S. arms purchases
05/20/2026 03:24 PM -
Business
Lai proposes billions in subsidies for small businesses, child-rearing
05/20/2026 03:22 PM